These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1482704)

  • 81. Popping a pill to regulate therapeutic protein delivery.
    Sansom C
    Mol Med Today; 2000 May; 6(5):179-80. PubMed ID: 10782060
    [No Abstract]   [Full Text] [Related]  

  • 82. Experimental hepatocyte transplantation and liver gene therapy.
    Demetriou AA
    Cell Transplant; 1993; 2(5):401-3. PubMed ID: 8162280
    [No Abstract]   [Full Text] [Related]  

  • 83. [Gene transfer as treatment for metabolic inherited liver diseases].
    Godoy JL
    J Pediatr (Rio J); 2000; 76(2):101-8. PubMed ID: 14647681
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Evaluating the state of the science for adeno-associated virus integration: An integrated perspective.
    Sabatino DE; Bushman FD; Chandler RJ; Crystal RG; Davidson BL; Dolmetsch R; Eggan KC; Gao G; Gil-Farina I; Kay MA; McCarty DM; Montini E; Ndu A; Yuan J;
    Mol Ther; 2022 Aug; 30(8):2646-2663. PubMed ID: 35690906
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Gene therapy in surgery: Part II: Application to septic shock and to organ transplantation.
    Rogy MA; Baumhofer JM; Beinhauer B; Brandmeier H; Eisenburger P; Losert UM; Philip R
    Acta Chir Austriaca; 1997; 29(1):22-26. PubMed ID: 32287331
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9.
    Stephens CJ; Kashentseva E; Everett W; Kaliberova L; Curiel DT
    Gene Ther; 2018 Apr; 25(2):139-156. PubMed ID: 29588497
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.
    Chiuchiolo MJ; Crystal RG
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4(Suppl 4):S352-69. PubMed ID: 27564673
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Progress with Recombinant Adeno-Associated Virus Vectors for Gene Therapy of Alpha-1 Antitrypsin Deficiency.
    Gruntman AM; Flotte TR
    Hum Gene Ther Methods; 2015 Jun; 26(3):77-81. PubMed ID: 26067712
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Optimized human factor IX expression cassettes for hepatic-directed gene therapy of hemophilia B.
    Zhang R; Wang Q; Zhang L; Chen S
    Front Med; 2015 Mar; 9(1):90-9. PubMed ID: 25663062
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium.
    Koirala A; Conley SM; Naash MI
    Biomaterials; 2013 Sep; 34(29):7158-67. PubMed ID: 23796578
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Gene delivery to pancreatic exocrine cells in vivo and in vitro.
    Houbracken I; Baeyens L; Ravassard P; Heimberg H; Bouwens L
    BMC Biotechnol; 2012 Oct; 12():74. PubMed ID: 23088534
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Evaluation of gene promoters for liver expression by hydrodynamic gene transfer.
    Nguyen AT; Dow AC; Kupiec-Weglinski J; Busuttil RW; Lipshutz GS
    J Surg Res; 2008 Jul; 148(1):60-6. PubMed ID: 18570932
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice.
    Nakai H; Fuess S; Storm TA; Muramatsu S; Nara Y; Kay MA
    J Virol; 2005 Jan; 79(1):214-24. PubMed ID: 15596817
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors.
    Thomas CE; Storm TA; Huang Z; Kay MA
    J Virol; 2004 Mar; 78(6):3110-22. PubMed ID: 14990730
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Current status of gene therapy for inherited lung diseases.
    Driskell RA; Engelhardt JF
    Annu Rev Physiol; 2003; 65():585-612. PubMed ID: 12524461
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction.
    Nakai H; Thomas CE; Storm TA; Fuess S; Powell S; Wright JF; Kay MA
    J Virol; 2002 Nov; 76(22):11343-9. PubMed ID: 12388694
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Variables affecting in vivo performance of high-capacity adenovirus vectors.
    Schiedner G; Hertel S; Johnston M; Biermann V; Dries V; Kochanek S
    J Virol; 2002 Feb; 76(4):1600-9. PubMed ID: 11799154
    [TBL] [Abstract][Full Text] [Related]  

  • 98. C/EBPalpha is required for differentiation of white, but not brown, adipose tissue.
    Linhart HG; Ishimura-Oka K; DeMayo F; Kibe T; Repka D; Poindexter B; Bick RJ; Darlington GJ
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12532-7. PubMed ID: 11606718
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Transient disruption of intercellular junctions enables baculovirus entry into nondividing hepatocytes.
    Bilello JP; Delaney WE; Boyce FM; Isom HC
    J Virol; 2001 Oct; 75(20):9857-71. PubMed ID: 11559819
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo.
    Nakai H; Yant SR; Storm TA; Fuess S; Meuse L; Kay MA
    J Virol; 2001 Aug; 75(15):6969-76. PubMed ID: 11435577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.